Associate Director, Go-To-Market and Field Strategy, Fertility and Value & Access
Boston, MA (Hybrid)
$128K/yr – $191K/yrSenior Level6+ years expFull time
Posted 5 days ago
Job Summary
Original Job Description
EMD Serono, Inc.
We aspire to create, improve and prolong life for people living with difficult-to-treat conditions like infertility, multiple sclerosis and cancer. We are imagining the future of healthcare by working to translate the discovery of molecules into potentially meaningful outcomes for people with serious unmet medical needs. EMD Serono is the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada. Our global roots go back more than 350 years. Today, we have approximately 1,100 employees around the US with commercial, clinical and research operations in Massachusetts.Community Guidelines: https://bit.ly/2nbPYl1
Marketing team
107
Employees
1.8K
Headquarters
Boston, Massachusetts, USA
Founded
1981
Traffic Signals
Monthly Visitors
24.3K
Monthly Google Ads Budget
$0.0
Traffic Source Mix
Search
46.2%
Direct
38.4%
Referral
8.9%
Social
4.9%
Paid
1.4%
Headcount Trend
Current headcount: ~1.8K
Recent News
Yahoo Finance
EMD Serono Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis
Nov 24, 2025
The American Bazaar
Trump announces lower prices for fertility medications
Oct 21, 2025
El Paso Inc.
Trump Announces Lower-Cost Fertility Drug Deal With EMD Serono
Oct 20, 2025
NewsBreak: Local News & Alerts
In Affordability Push, EMD Serono Joins TrumpRx While Roche Launches DTC Program
Oct 17, 2025
Yahoo
EMD Serono partners US government to widen IVF access
Oct 17, 2025
Benzinga
EMD Serono, CVS Health To Partner On TrumpRx Fertility Program Launching In 2026
Oct 17, 2025
Sahm
EMD Serono, CVS Health To Partner On TrumpRx Fertility Program Launching In 2026
Oct 16, 2025
MarketScreener
EMD Serono announces agreement with U.S. government to expand access to IVF therapies
Oct 16, 2025
Business Wire
EMD Serono Announces Unprecedented Agreement with U.S. Government to Expand Access to IVF Therapies
Oct 16, 2025
Seeking Alpha
EMD Serono to offer discounted fertility treatments in TrumpRx IVF program
Oct 16, 2025
Business Wire
EMD Serono to Present New Data Highlighting Durable Effects of MAVENCLAD
Sep 17, 2025
Morningstar.com
NORD's 2025 Rare Diseases & Orphan Products Breakthrough Summit to Spotlight CEOs, Investors, and Regulatory Leaders Driving Innovation
Aug 21, 2025
EIN Presswire
Thousands Nationwide to Walk in Honor of Ovarian Cancer Awareness Month
Aug 12, 2025
IndiaTimes
Donald Trump's crackdown at pharma: 'Americans need lower drug prices'; sets 29 September deadline or face action
Aug 1, 2025
TechTarget
Trump urges top drugmakers to cut U.S. prescription drug costs
Aug 1, 2025
MarketScreener
Trump back on the attack against the pharmaceutical industry
Aug 1, 2025
pharmaphorum
Trump gives pharma ultimatum on most favoured nation pricing
Jul 31, 2025
Investing.com
Trump demands pharma CEOs lower drug prices within 60 days
Jul 31, 2025
FiercePharma
White House threatens to 'deploy every tool in our arsenal' to implement most-favored-nation drug pricing
Jul 31, 2025
EIN Presswire
Poly ADP-Ribose Polymerase PARP Inhibitors Report 2025 – For Strategy Officers And Market Intelligence Teams
Jul 24, 2025
EIN Presswire
CEO Roundtable on Cancer Appoints Two Esteemed Oncology Leaders to Life Sciences Council
Jul 7, 2025
BioSpace
EMD Serono Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025
Jun 13, 2025
Yahoo Finance
EMD Serono Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025
Jun 12, 2025
BioWorld Financial Watch
In the clinic for May 29, 2025
May 29, 2025
BioSpace
EMD Serono Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025
May 23, 2025
Business Wire
EMD Serono Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025
May 22, 2025
Business Wire
EMD Serono Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) with Active Lupus Rash
May 21, 2025
PharmiWeb
Longwood Healthcare Leaders to Convene Top Life Science E...
May 15, 2025
Seattle TechFlash
Bank to consolidate HQ into former EMD Serono office
May 1, 2025
BostonGlobe.com
Fernández Alcalde takes the reins at EMD Serono, one of Boston’s newest biotechs
Mar 24, 2025
The Business Journals
EMD Serono’s new president is on the hunt for deals in Boston
Mar 21, 2025
EIN Presswire
Immuno Oncology Market Anticipated to Reach USD 305.35 Billion, at a Notable 9.28% CAGR by 2034
Mar 18, 2025
EIN Presswire
Rebif Market Forecast 2025-2034: Comprehensive Insights On Market Size, Growth Factors, Trends, Competitive Landscape
Mar 12, 2025
Medical Marketing and Media
Selma Blair collabs with EMD Serono for DTC campaign about relapsing MS
Mar 10, 2025
prnewswire.co.uk
BAVENCIO Continues to Strengthen Its Position in the Immuno-Oncology Landscape | DelveInsight
Mar 10, 2025
PR Newswire
BAVENCIO Continues to Strengthen Its Position in the Immuno-Oncology Landscape | DelveInsight
Mar 10, 2025
PR Newswire
TEPMETKO Continues to Strengthens its Position as a Leading METex14 Skipping NSCLC Therapy | DelveInsight
Mar 6, 2025
prnewswire.co.uk
TEPMETKO Continues to Strengthens its Position as a Leading METex14 Skipping NSCLC Therapy | DelveInsight
Mar 6, 2025
FemTech World
EMD Serono and SiS launch corporate accelerator programme for women's health innovators
Mar 5, 2025
Oncodaily
Antonio Gualberto: I’m starting a new position as Global Head, Due Diligence Oncology at EMD Serono
Jan 16, 2025
Boston Business Journal
Five things: Hotel unions, hospital costs, Newbury St. shopping, and life after iRobot
Dec 13, 2024
Boston Business Journal
Petri Dish: EMD Serono’s new president; Prostate cancer drug success
Dec 12, 2024
BioWorld Financial Watch
Appointments and advancements for Dec. 11, 2024
Dec 11, 2024
Business Wire
EMD Serono Appoints Miguel Fernández Alcalde to Lead North American Healthcare Business
Dec 10, 2024
citybiz
EMD Serono Appoints Miguel Fernández Alcalde to Lead North American Healthcare Business
Dec 10, 2024
Business Wire
EMD Serono Appoints Miguel Fernández Alcalde to Lead North American Healthcare Business
Dec 10, 2024
FiercePharma
CORRECTED: Takeda to cut another 220 jobs in Massachusetts, as Merck KGaA plots office move
Jul 2, 2024
Yahoo Finance
EMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
May 23, 2024
Fierce Pharma
Merck KGaA earmarks €300M for an advanced research center at its HQ site
Apr 29, 2024
Business Wire
EMD Serono Presents New MAVENCLAD® Data Supporting Cognitive Function Benefits
Mar 6, 2024
The Pharma Letter
FDA grants traditional approval for Merck's Tepmetko
Mar 6, 2024
Morningstar
EMD Serono Presents New MAVENCLAD® Data Supporting Cognitive Function Benefits
Feb 29, 2024
Yahoo Finance
Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in ...
Jan 22, 2024
Endpoints News
EMD Serono lays out MS therapies' immune-system suppression risks in new campaign
Jan 17, 2024
Endpoints News
Gilde Healthcare's €140M; EMD Serono to move US HQ to Boston; Arcturus up for $35M milestone
Nov 15, 2023
Boston Business Journal
EMD Serono to move HQ to Seaport from the suburbs
Nov 14, 2023
Bost.com
EMD Serono headquarters plans to join biopharma cluster in Boston’s Seaport
Jan 1, 1970
News
EMD Serono Announces Plans for New U.S. Healthcare Headquarters in Boston's Seaport District
Jan 1, 1970